{"changeSha256":"ede37796c002d3a1dd4cd7b5713ae8f317ec8f6cbd8e1749a363fef8d3c83135","changedAt":"2026-11-15","changedFields":[{"after":"PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.","before":"PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.","field":"Summary"},{"after":"2026-11-12","before":"2026-07-21","field":"Cited source date"},{"after":"2026-11-15","before":"2026-08-10","field":"Source observed date"},{"after":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9-r2","before":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9","field":"Cited source records"},{"after":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9-r2","before":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9","field":"Headline citations"},{"after":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9-r2","before":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9","field":"Summary citations"},{"after":"1. PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide. [sources: ctg-observation-nct06299098-2026-07-21-3f43d1be33b9-r2]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct06299098-2026-07-21-3f43d1be33b9-r2]","before":"1. PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide. [sources: ctg-observation-nct06299098-2026-07-21-3f43d1be33b9]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct06299098-2026-07-21-3f43d1be33b9]","field":"Attributable context"},{"after":"ac8b8fbebfec0cf7c2103200aabff05341060cb529bf54ef4662b0b5175d3d73","before":"5daab950986505011c46590a906c6633448e2a82fecd91776e83eb5058256666","field":"Source snapshot commitment"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06299098-semaglutide/#version-2","version":2},"id":"story:clinicaltrials-gov-nct06299098-semaglutide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"record-updated","notice":"ClinicalTrials.gov posted a newer version of NCT06299098, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.","peptideSlugs":["semaglutide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06299098-semaglutide/#version-1","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-observation-nct06299098-2026-07-21-3f43d1be33b9-r2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06299098 · retained source version 2026-11-12:c1679275301a635d05f841b65a26d953bda55a1c1d957a48fb93f934e1c46713","url":"https://clinicaltrials.gov/study/NCT06299098","verifiedAt":"2026-11-15"}],"subject":{"slug":"clinicaltrials-gov-nct06299098-semaglutide","type":"story"}}
